Trump has claimed the company delayed an announcement for its vaccine until after the 2020 presidential election.

The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...

With concerns mounting and speculation swirling, the particulars of President Donald Trump’s much-touted “Liberation Day” ...

Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The ...

Not long after President Donald Trump’s inauguration, the administration’s economic staff went to work on a daunting task: ...

Just two days after Democrat Joe Biden was declared the winner of the 2020 presidential election, drugmaker Pfizer announced ...

Trump announced a 10% tariff on all U.S. trading partners, in addition to higher reciprocal tariffs on the EU and China. But ...

By Sabrina Valle NEW YORK (Reuters) -Large deals involving pharmaceutical and biotech companies are stalling as executives ...

Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are ...

The fear of a trade war over pharmaceuticals between the EU and the US has been avoided for now, but the European Commission ...

Citi analyst Geoff Meacham keeps a Neutral rating on Pfizer (PFE) with a $27 price target after the Wall Street Journal reported that U.S.